Solel Partners’s Universal Health Services UHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-182,341
Closed -$16.1M 29
2022
Q3
$16.1M Hold
182,341
2.89% 14
2022
Q2
$18.4M Sell
182,341
-170,059
-48% -$21.3M 3.38% 11
2022
Q1
$51.1M Sell
352,400
-75,000
-18% -$10.4M 11.04% 3
2021
Q4
$55.4M Buy
427,400
+89,000
+26% +$11.4M 11.91% 1
2021
Q3
$46.8M Hold
338,400
9.42% 2
2021
Q2
$49.6M Hold
338,400
12% 3
2021
Q1
$45.1M Hold
338,400
11.26% 3
2020
Q4
$46.5M Buy
338,400
+18,000
+6% +$2.24M 11.49% 3
2020
Q3
$34.3M Buy
320,400
+79,900
+33% +$8.55M 10.99% 3
2020
Q2
$22.3M Buy
+240,500
New +$24.1M 8.47% 3

Other funds holding UHS

Solel Partners's UHS Position: Q4 2022 in Review

Solel Partners sold out of Universal Health Services (UHS) in Q4 2022, closing a stake of 182,341 shares — an estimated $16.1M sold.

Solel Partners first reported a position in UHS in Q2 2020 and held it in 10 quarters. The position peaked at $55.4M in Q4 2021. 435 funds tracked by Wall St. Rank hold UHS as of Q4 2022.

  • Solel Partners reported no remaining Universal Health Services position as of Q4 2022 after selling out during the quarter.
  • Solel Partners sold 182,341 Universal Health Services shares in Q4 2022, an estimated $16.1M.
  • Solel Partners first reported a position in Universal Health Services in Q2 2020 and held it in 10 quarters.
  • Solel Partners's Universal Health Services position peaked at $55.4M in Q4 2021.
  • 435 funds tracked by Wall St. Rank held Universal Health Services as of Q4 2022.

Based on Solel Partners's 13F filing for Q4 2022, filed 14 Feb 2023.